-
admin
Posts
<div>NIRA Dynamics’ Wheel Safety solutions would annually prevent hundreds of accidents caused by wheel detachments</div>
LINKÖPING, Sweden, June 11, 2024 /PRNewswire/ — Following the Swedish Tire Safety Council’s alarming report on wheel detachment incidents, NIRA Dynamics reaffirms the value of its...
Best’s Market Segment Report: AM Best Maintains Stable Outlook on UK Life Insurance Segment
LONDON–(BUSINESS WIRE)–#insurance—AM Best is maintaining its market segment outlook on the U.K. life insurance segment at stable. In its new Best’s Market Segment Report, “Market...
<div>ROHM’s New “TRCDRIVE pack (TM)” with 2-in-1 SiC Molded Module: Significantly Reduces xEV Inverter Size</div>
– Industry-leading* Power Density Achieved by Integrating 4th Generation SiC MOSFETs in Compact Package – KYOTO, Japan, June 11, 2024 /PRNewswire/ — ROHM Co., Ltd....
Sensor Market for Automated Vehicles worth $19.1 billion by 2030 Globally, at a CAGR of 62.6%, says MarketsandMarkets™
Chicago, June 11, 2024 (GLOBE NEWSWIRE) — Sensor Market for Automated Vehicles is projected to grow from USD 0.4 billion in 2022 to USD 19.1...
XTransfer and Banking Circle Announce Strategic Partnership
Collaboration Set to Boost Payment Capabilities for Importers/Exporters in Europe and the Middle East HONG KONG, June 11, 2024 /PRNewswire/ — XTransfer, the World’s Leading...
Alvotech and STADA add to Strategic Alliance through Denosumab Partnership
STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets...
Bio-Butadiene Market Estimated to Reach $94 million by 2029 Globally, at a CAGR of 10.1%, says MarketsandMarkets™
Chicago, June 11, 2024 (GLOBE NEWSWIRE) — The Bio-butadiene Market is projected to reach USD 94 million by 2029, at a CAGR of 10.1% from USD...
Alvotech and STADA add to strategic alliance through denosumab partnership
STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets...
Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials
— Lead Program, BPT567, will be the first PD1-IL18 immunoconjugate to enter the clinic; Phase 1/2a study in solid tumors expected to begin in 2H...
Silicon Tetrachloride Market to surpass $3.33 billion by 2031, at a CAGR of 3.7%, says Coherent Market Insights
The global Silicon Tetrachloride Market, valued at $2.58 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to...